Journal of Veterinary Dentistry · 1995 · 16 citations · 6 references
DentistryPeriodonticsPeriodontologyDiagnostic MicrobiologyPeriodontal MedicinePeriodontal PathogenesisGingival DiseaseMicrobiological AnalysisPeriodontal DiseasePeriodontal InflammationPeriodontal MicrobiologyVeterinary Antimicrobial TherapyAmoxicillin TherapyAntimicrobial Susceptibility InterpretationGingival InfectionGram-negative AnaerobesIn Vitro Drug Susceptibility TestingPeriodontal InfectionsSubgingival Antibiotic Therapy
The aerobic and anaerobic flora from gingival pockets of 49 dogs with severe gingivitis and periodontitis were cultured. The susceptibility of each isolate to four antimicrobial agents currently approved for veterinary use in the USA (amoxicillin-clavulanic acid; clindamycin; cefadroxil; and enrofloxacin) was determined. Amoxicillin-clavulanic acid (Clavamox ® Pfizer Animal Health) had the highest in-vitro susceptibility against all isolates (96%), all aerobes (94%) and all anaerobes (100%) tested. For gram-negative aerobes, enrofloxacin (Baytril ® , Bayer Corp.) had the highest in-vitro susceptibility activity. For bacteria associated with treatment of gingivitis, which typically are mixed aerobic/anaerobic and gram-positive/gram-negative organisms, the antimicrobial of choice for clinical use based on these susceptibility tests is amoxicillin-clavulanic acid.
6
The Periodontal Disease Index (PDI)
Sigurd P. Ramfjord · The Journal of Periodontology · 1967 · 176 citations